Hervé Canton - Concepedia

Concepedia

Author

Hervé Canton

Servier (France)

Also Known As

H CANTON, H Canton, H. CANTON, H. Canton, Herve Canton, Hervé Canton

22

Publications

1.9K

Citations

15

H-Index

34

Concepts

All Affiliations

Servier (France)Vanderbilt University Fondation pour la Recherche Médicale

HC

About

Hervé Canton is an author at Servier (France) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	441
2	Social Sciences	4	4	248
3	Biochemistry	3	3	107
4	Health Sciences	1	1	52
5	Natural Sciences	1	1	1K

Hervé Canton

×

16

Publications

1.9K

Citations

15

H-Index

	Year	Citations
Regulation of serotonin-2C receptor G-protein coupling by RNA editing Colleen Burns, H. M. Chu, Susan M. Rueter, Nature Molecular PhysiologyG Protein-coupled ReceptorNatural SciencesReceptor (Biochemistry)Molecular Biology	1997	1K
Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites Hervé Canton, Laurence Verrièle, Françis C. Colpaert European Journal of Pharmacology 5-Ht1c SitesPsychiatryPsychotic DisorderAtypical AntipsychoticsMedicine	1990	171
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Hervé Canton, Ronald B. Emeson, E L Barker, Molecular Pharmacology	1996	131
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. M J Millan, Jean‐Michel Rivet, Hervé Canton, Journal of Pharmacology and Experimental Therapeutics	1993	127
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. M J Millan, Hervé Canton, Alain P. Gobert, Journal of Pharmacology and Experimental Therapeutics	1994	76
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively Mark J. Millan, Jean‐Michel Rivet, Hervé Canton, European Journal of Pharmacology Functional SelectivityMedicinePostsynaptic SitesMolecular BiologyMechanism Of Action	1993	54
S 14506: A novel, potent, high‐efficacy 5‐HT<sub>1A</sub> agonist and potential anxiolytic agent Françis C. Colpaert, Wouter Koek, John Lehmann, Drug Development Research Potential Anxiolytic AgentPharmacotherapyHigh‐efficacy 5‐HtSystem PharmacologyExperimental Pharmacology	1992	52
S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. M J Millan, Jean‐Michel Rivet, Hervé Canton, Journal of Pharmacology and Experimental Therapeutics	1992	44
WAY 100,135 and (−)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo Franćoise Lejeune, Jean‐Michel Rivet, Alain P. Gobert, European Journal of Pharmacology Signal TransductionMedicineSynaptic TransmissionPhysiology5-Ht1a Autoreceptors	1993	41
Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptormediated phosphoinositide (PI) turnover by clozapine in the rat: A comparison to other antipsychotics Hervé Canton, Laurence Verrièle, Mark J. Millan Neuroscience Letters Competitive AntagonismPsychiatryMedicinePsychopharmacologySchizophrenia	1994	41

Page 1